MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1073/pnas.2613799123

Медицинская библиотека · Proceedings of the National Academy of Sciences of the United States of America · 2026

A highly potent bispecific antibody confers complete protection against SFTSV in preclinical models.

Guo Xiaoping, Wan Fujian, Li Wujian, Zou Qingcui, Li Entao, Wang Weiqi, Li Fangxu, Zhou Zunhao, Yang Xiaoman, Yang Qiyuan, Wang Xinyu, Gao Xiang, He Haoyi, Xie Wenyu, Hou Aiqing, Su Yanan, He Hongliang, Li Minghua, Shu Bo, Chiu Sandra

СтатьяПеревод в очереди

Аннотация

Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging bunyavirus that causes severe human disease, with a case fatality rate of up to 30%. However, no licensed therapeutics are currently available for clinical use. Here, we identified two SFTSV neutralizing nanobodies (Nbs), N2C1 and N2D2, which inhibited both viral attachment and membrane fusion. Structural analysis revealed that N2C1 spanned Gn domain I and domain III, while N2D2 targeted domain I, located at the inner and outer sides of the Gn-Gc hexamer crown, respectively. They also exhibited synergistic neutralization, and their bispecific antibody (bsAb) displayed dramatically enhanced neutralizing potency. In a lethal mouse model, the bsAb demonstrated superior protective efficacy over the parental Nbs in both preexposure and postexposure administration regimens. More importantly, in preclinical ferret models, the bsAb N2D2-Fc-N2C1 conferred complete protection against SFTSV not only at a low dose of 5 mg/kg but also when administered as late as 2 d postinfection. These results demonstrate the potent protective efficacy of N2D2-Fc-N2C1, supporting its development as a promising clinical candidate against SFTSV infection.

Для цитирования: Guo Xiaoping, Wan Fujian, Li Wujian, Zou Qingcui, Li Entao, Wang Weiqi, Li Fangxu, Zhou Zunhao, Yang Xiaoman, Yang Qiyuan, Wang Xinyu, Gao Xiang, He Haoyi, Xie Wenyu, Hou Aiqing, Su Yanan, He Hongliang, Li Minghua, Shu Bo, Chiu Sandra. A highly potent bispecific antibody confers complete protection against SFTSV in preclinical models.. Proceedings of the National Academy of Sciences of the United States of America. 2026. DOI: 10.1073/pnas.2613799123.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.